Type a description of this image
Type a description of this image

News

Contact →
Type a description of this image

BRC Therapeutics Announces Peer-Reviewed Publication on Navigating Drug Development Pathways for Botanical Cannabinoid Medicines

PR Newswire

Jan 6, 2026
Type a description of this image

ACT LAB Moves Ohio Cannabis Testing Operations to New Laboratory in Columbus

ACT LAB

Nov 18, 2025
Type a description of this image

ACT LAB Expands Pennsylvania Operations with New Cannabis Testing Laboratory in Harrisburg

ACT LAB

Oct 28, 2025
Type a description of this image

BRC-002 receives Orphan Drug Designation from FDA for Complex Regional Pain Syndrome

PR Newswire

Dec 4, 2024
Type a description of this image

Biopharmaceutical Research Company Announces First Dose of BRC-002, a First-in-Class Cannabinoid Therapeutic for Complex Regional Pain Syndrome (CRPS), in Investigator-Initiated Study

PR Newswire

Oct 4, 2024
Type a description of this image

City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast cancer

PR Newswire

Sep 13, 2024
Type a description of this image

QNTM Brings in New CEO to Drive Next Phase Commercial Growth

QNTM Labs

Mar 21, 2024
Type a description of this image

New Scientific Discoveries in CBD’s Ability to Reduce Pain and Inflammation

NextEvo Naturals

Mar 20, 2024
Type a description of this image

Nalu Bio and PIPA Bring Cannabinoid Combinations To CPG Brands in First-Of-Its-Kind Partnership Powered by AI

PR Newswire

Feb 9, 2024